Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report-Reference-Cited by-同舟云学术

Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report

Published:2022 Issue:1 Volume:6 Page:
ISSN:2514-1775
Container-title:Rheumatology Advances in Practice
language:en
Short-container-title:

Author:

Matsuda Shogo¹,Yamamoto Mahiro¹,Kotani Takuya¹,Takeuchi Tohru¹^ORCID

Affiliation:

1. Department of Internal Medicine (IV), Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://academic.oup.com/rheumap/advance-article-pdf/doi/10.1093/rap/rkac003/42436954/rkac003.pdf

Reference10 articles.

1. Interstitial lung disease in systemic sclerosis;Bussone;Autoimmun Rev,2011

2. May capillaroscopy be a candidate tool in future algorithms for SSC-ILD: are we looking for the holy grail? A systematic review;Smith;Autoimmun Rev,2020

3. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative;van den Hoogen;Ann Rheum Dis,2013

4. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis;Smith;Autoimmun Rev,2020

5. Reproducibility of the scleroderma pattern assessed by wide-field capillaroscopy in subjects suffering from Raynaud’s phenomenon;Boulon;Rheumatology (Oxford),2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on: Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD;Rheumatology;2022-05-12

2. Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis–interstitial lung disease: a case report;Rheumatology Advances in Practice;2022

3. Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply;Rheumatology Advances in Practice;2022